Evidence map›Paper›PMID 29876236›Full record

ArticleBalkan journal of medical genetics : BJMG2017

Differential Expression of FGFRs Signaling Pathway Components in Bladder Cancer: A Step Toward Personalized Medicine.

Ousati Ashtiani Z, Tavakkoly-Bazzaz J, Salami Sa, Pourmand Mr, Mansouri F, Mashahdi R, Pourmand G

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Balkan journal of medical genetics : BJMG, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.3field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. The importance of personalized medicine in urological cancers.Journal of diabetes and metabolic disorders · 2022
    Review
  4. Review
  5. Role of FGFR3 in Urothelial Carcinoma.Iranian journal of pathology · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Ousati Ashtiani ZUrology Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Tavakkoly-Bazzaz JDepartment of Medical Genetics, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Salami SaDepartment of Biotechnology, University of Tehran, Tehran, Iran.
Pourmand MrDivision of Microbiology, Department of Pathobiology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Mansouri FDepartment of Medical Immunology and Genetics, Faculty of Medicine, Urmia University of Medical Sciences, Urmia, Iran.
Mashahdi RUrology Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Pourmand GUrology Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Tehran University of Medical Sciences · IRUrmia University · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Variations Improper activation and inappropriate expression of fibroblast growth factor receptors (

Indexed as

Bladder cancer (BC)FGFR1FGFR3FGFR signalingTargeted therapy

Identifiers

PMID29876236
PMCPMC5972506
OpenAlexW2806434743

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.